BNP Paribas Asset Management
SANA icon

BNP Paribas Asset Management’s Sana Biotechnology SANA Stock Holding History

BNP Paribas Asset Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.53K Buy
2,962
+681
+30% +$2.68K ﹤0.01% 2243
2025
Q4 		$9K Buy
2,281
+695
+44% +$3.11K ﹤0.01% 2184
2025
Q3 		$6K Buy
+1,586
New +$5.73K ﹤0.01% 1791

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

BNP Paribas Asset Management's SANA Position: Q1 2026 in Review

BNP Paribas Asset Management increased its Sana Biotechnology (SANA) stake by 30% in Q1 2026, buying an estimated $2.68K and bringing the position to 2,962 shares worth $8.53K. The position accounts for ﹤0.01% of the portfolio, ranked #2243.

BNP Paribas Asset Management first reported a position in SANA in Q3 2025 and has held it in 3 quarters since. The position peaked at $9K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • BNP Paribas Asset Management held 2,962 shares of Sana Biotechnology worth $8.53K as of Q1 2026.
  • BNP Paribas Asset Management bought 681 Sana Biotechnology shares in Q1 2026, an estimated $2.68K.
  • Sana Biotechnology made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #2243 holding.
  • BNP Paribas Asset Management first reported a position in Sana Biotechnology in Q3 2025 and has held it in 3 quarters since.
  • BNP Paribas Asset Management's Sana Biotechnology position peaked at $9K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.